UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.077

Sortiert nach

Venous thromboembolism in cancer patients: a population-based cohort study

Blood, 2021-04, Vol.137 (14), p.1959-1969

2021

Volltextzugriff (PDF)

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

Journal of thrombosis and haemostasis, 2015-12, Vol.13 (12), p.2187-2191

2015

Volltextzugriff (PDF)

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.56-70

2013

Volltextzugriff (PDF)

Treatment of venous thromboembolism

Journal of thrombosis and haemostasis, 2005-08, Vol.3 (8), p.1554-1560

2005

Volltextzugriff (PDF)

Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts

BMJ (British Medical Journal), 2010-05, Vol.340 (7753), p.962-962

International edition, 2010

Volltextzugriff (PDF)

International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.71-80

2013

Volltextzugriff (PDF)

ADAMTS‐13 and von Willebrand factor predict venous thromboembolism in patients with cancer

Journal of thrombosis and haemostasis, 2016-02, Vol.14 (2), p.306-315

2016

Volltextzugriff (PDF)

Accuracy of clinical decision rule, D‐dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism

Journal of thrombosis and haemostasis, 2006-05, Vol.4 (5), p.1042-1046

2006

Volltextzugriff (PDF)

D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial

Journal of thrombosis and haemostasis, 2014-04, Vol.12 (4), p.479-487

2014

Volltextzugriff (PDF)

The original and simplified Wells rules and age‐adjusted D‐dimer testing to rule out pulmonary embolism: an individual patient data meta‐analysis

Journal of thrombosis and haemostasis, 2017-04, Vol.15 (4), p.678-684

2017

Volltextzugriff (PDF)

Cancer and thrombosis: from molecular mechanisms to clinical presentations

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (s1), p.246-254

2007

Volltextzugriff (PDF)

The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1597-1602

2013

Volltextzugriff (PDF)

Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score

Journal of thrombosis and haemostasis, 2017-09, Vol.15 (9), p.1764-1769

2017

Volltextzugriff (PDF)

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

Journal of thrombosis and haemostasis, 2007-11, Vol.5 (11), p.2178-2185

2007

Volltextzugriff (PDF)

The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer

Thrombosis research, 2017-02, Vol.150, p.30-32

2017

Volltextzugriff (PDF)

NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands

Thrombosis journal, 2018-04, Vol.16 (1), p.7-7, Article 7

2018

Volltextzugriff (PDF)

Sex‐specific differences in the presenting location of a first venous thromboembolism

Journal of thrombosis and haemostasis, 2017-07, Vol.15 (7), p.1344-1350

2017

Volltextzugriff (PDF)

Short‐ and long‐acting synthetic pentasaccharides

Journal of internal medicine, 2003-10, Vol.254 (4), p.335-342

2003

Volltextzugriff (PDF)

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Thrombosis research, 2020-01, Vol.185, p.13-19

2020

Volltextzugriff (PDF)

Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists

Journal of thrombosis and haemostasis, 2015-09, Vol.13 (9), p.1590-1596

2015

Volltextzugriff (PDF)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Cochrane database of systematic reviews, 2005-01 (1), p.CD002071

2005

Volltextzugriff (PDF)

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study

BJOG : an international journal of obstetrics and gynaecology, 2018-11, Vol.125 (12), p.1581-1589

2018

Volltextzugriff (PDF)

Systematic review on the effect of glucocorticoid use on procoagulant, anti‐coagulant and fibrinolytic factors

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2483-2493

2010

Volltextzugriff (PDF)

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

Journal of thrombosis and haemostasis, 2005-01, Vol.3 (1), p.103-111

2005

Volltextzugriff (PDF)

Improving the diagnostic management of upper extremity deep vein thrombosis

Journal of thrombosis and haemostasis, 2017-01, Vol.15 (1), p.66-73

2017

Volltextzugriff (PDF)

1 – 25 von 1.077

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(964)
Mit Volltextzugriff
(797)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(750)
Humans
(712)
Life Sciences & Biomedicine
(708)
Female
(432)
Biological And Medical Sciences
(395)
Male
(381)
Medical Sciences
(365)
Middle Aged
(329)
Aged
(269)
Adult
(268)
Cardiovascular System & Cardiology
(268)
Hematology
(247)
Peripheral Vascular Disease
(227)
General & Internal Medicine
(164)
Medicine, General & Internal
(152)
Risk Factors
(144)
Prospective Studies
(114)
Anticoagulants - Therapeutic Use
(107)
Aged, 80 And Over
(105)
Adolescent
(99)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Venous thromboembolism in cancer patients: a population-based cohort study

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Treatment of venous thromboembolism

Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts

International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

ADAMTS‐13 and von Willebrand factor predict venous thromboembolism in patients with cancer

Accuracy of clinical decision rule, D‐dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism

D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial

The original and simplified Wells rules and age‐adjusted D‐dimer testing to rule out pulmonary embolism: an individual patient data meta‐analysis

Cancer and thrombosis: from molecular mechanisms to clinical presentations

The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH

Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer

NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands

Sex‐specific differences in the presenting location of a first venous thromboembolism

Short‐ and long‐acting synthetic pentasaccharides

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study

Systematic review on the effect of glucocorticoid use on procoagulant, anti‐coagulant and fibrinolytic factors

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

Improving the diagnostic management of upper extremity deep vein thrombosis

Suchergebnisse filtern